OPEN END TURBO OPTIONSSCHEIN SHORT - LONZA GROUP Share Price

Certificat

DE000GG5TDS0

Real-time Bid/Ask 10:44:31 01/07/2024 pm IST
9.6 EUR / 9.7 EUR -0.72% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - LONZA GROUP
Current month-2.51%
1 month+23.98%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
01/24/01 9.41 -3.19%
28/24/28 9.72 -2.99%
27/24/27 10.02 +6.48%
26/24/26 9.41 -6.92%
25/24/25 10.11 -8.59%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 02:13 pm IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying LONZA GROUP AG
Issuer Goldman Sachs
WKN GG5TDS
ISINDE000GG5TDS0
Date issued 25/03/2024
Strike 580.6 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 6.07
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 11.13
Lowest since issue 3.4
Spread 0.1
Spread %1.02%

Company Profile

Lonza Group AG is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - bio-pharmaceuticals (55.4%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.; - capsules and dosing solutions for biopharmaceuticals, drugs and nutrition products (17.3%). In addition, the group offers nutritional ingredients; - small molecule drug substances (13.4%); - technologies and platforms for manufacturing processes and production of cell and gene therapies (10.4%); - other (3.5%). Net sales are distributed geographically as follows: Switzerland (17.4%), Europe (31.7%), the United States (31.8%), the Americas (3.2%), Japan (8.1%), Asia (7.5%) and other (0.3%).
Sector
-
More about the company

Ratings for Lonza Group AG

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Lonza Group AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
490.4 CHF
Average target price
586 CHF
Spread / Average Target
+19.49%
Consensus